Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02578797
Title A JNJ-56021927 (ARN-509) QT/QTc Study
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors NCT02578797
Indications

prostate adenocarcinoma

Therapies

Apalutamide

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.